Therefore, we hypothesized that ANXA1 could be of therapeutic use in Alzheimer’s disease by regulating blood–brain barrier leakage, reducing microvascular damage and amyloid-β pathology. The gene discussed is ANXA1; the disease is Alzheimer disease.